Cape Verde vs Indonesia: The number of people with susceptibility test result for rifampicin
Cape Verde
69.01
in 2021
Indonesia
72.55
in 2021
Cape Verde rank
105th
Indonesia rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Cape Verde
- Indonesia
How they compare
Indonesia currently reports 72.55 against 69.01 in Cape Verde, a difference of 3.54.
That makes Indonesia's figure about 1.1 times Cape Verde's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Cape Verde ahead.
Cape Verde ranks 105th and Indonesia ranks 102nd of 146 countries.
Across the 2 decades both report, Cape Verde averaged higher in 1 and Indonesia in 1.
Head to head by decade
| Decade | Cape Verde | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.97 | 30.84 | 26.13 | Cape Verde |
| 2020s | 60 | 65.06 | 5.06 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cape Verde or Indonesia?
- Indonesia, at 72.55 against 69.01 in Cape Verde as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cape Verde and Indonesia?
- 3.54, with Indonesia ahead.
- How many years of comparable data are there for Cape Verde and Indonesia?
- 5 years are reported by both, from 2017 to 2021.
- How do Cape Verde and Indonesia rank globally for the number of people with susceptibility test result for rifampicin?
- Cape Verde ranks 105th and Indonesia ranks 102nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.